Inhibition of the Progression of Skin Inflammation, Fibrosis, and Vascular Injury by Blockade of the <scp>CX</scp><sub>3</sub><scp>CL</scp>1/<scp>CX</scp><sub>3</sub><scp>CR</scp>1 Pathway in Experimental Mouse Models of Systemic Sclerosis - Concepedia

Concepedia

Publication | Closed Access

Inhibition of the Progression of Skin Inflammation, Fibrosis, and Vascular Injury by Blockade of the <scp>CX</scp><sub>3</sub><scp>CL</scp>1/<scp>CX</scp><sub>3</sub><scp>CR</scp>1 Pathway in Experimental Mouse Models of Systemic Sclerosis

19

Citations

41

References

2019

Year

Vu Huy Luong, Akira Utsunomiya, Takenao Chino, Le Huu Doanh, Takashi Matsushita, Takashi Obara, Yoshikazu Kuboi, Naoto Ishii, Akihito Machinaga, Hideaki Ogasawara,

Arthritis & Rheumatology

Abstract

Anti-CX<sub>3</sub> CL1 mAb therapy may be a novel approach for treating early skin fibrosis in inflammation-driven fibrotic skin disorders such as SSc.

References

	Year	Citations

Page 1